Cellibre is a series a startup based in United States. 1 investor tracked. Status: zombie.
Cellibre is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cellibre is a synthetic biology company that employs an organism-agnostic approach to turn cells into specialized, sustainable factories for the manufacture of ingredients and products.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.